| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
3 companies
McManus Michael A Jr is a Director at UNITED STATES ANTIMONY CORP with holdings across 3 companies. Recent SEC Form 4 filings include 7 buys and 4 sells.
Estimated insider holdings value: $6.6M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 10, 2024 | UAMY United States Antimony Corp | Director | Buy | 70,000 | $1.46 | $102,060.00 | +26.1% | -6.5% | +325.9% | |
| Nov 18, 2024 | UAMY United States Antimony Corp | Director | Buy | 50,000 | $0.57 | $28,250.00 | +22.9% | +221.2% | +1142.5% | |
| Aug 14, 2024 | UAMY United States Antimony Corp | Director | Buy | 135,000 | $0.38 | $51,705.00 | +162.0% | +61.3% | +974.4% | |
| Mar 19, 2021 | NVAX Novavax Inc | Director | Sell | 4,000 | $220.78 | $883,110.00 | -21.2% | -21.2% | -63.9% | |
| Aug 18, 2020 | NVAX Novavax Inc | Director | Sale+OE | 8,000 | $146.00 | $1,168,000.00 | -44.6% | - | - | |
| Nov 18, 2019 | NVAX Novavax Inc | Director | Sell | 3,929 | $3.82 | $15,014.67 | -28.3% | - | - | |
| May 19, 2017 | EML Eastern Co | Director | Buy | 5,000 | $25.90 | $129,500.00 | +152.3% | - | - | |
| May 12, 2017 | NVAX Novavax Inc | Director | Buy | 20,000 | $0.97 | $19,396.00 | +7.8% | - | - | |
| May 11, 2017 | NVAX Novavax Inc | Director | Buy | 10,000 | $0.84 | $8,400.00 | +4.0% | - | - | |
| Sep 21, 2016 | NVAX Novavax Inc | Director | Buy | 30,000 | $1.61 | $48,297.00 | +13.8% | - | - |